Genetics and molecular pathogenesis of the myotonic dystrophies

被引:28
作者
Day J.W. [1 ]
Ranum L.P.W. [1 ]
机构
[1] Department of Neurology, Institute of Human Genetics, Univ. of Minnesota Sch. of Medicine, Minneapolis, MN 55455
关键词
Repeat Expansion; Myotonic Dystrophy; Myotonic Dystrophy Type; Dystrophia Myotonica Protein Kinase; Cellular Nucleic Acid Binding Protein;
D O I
10.1007/s11910-005-0024-1
中图分类号
学科分类号
摘要
Pathogenic repeat expansions were initially identified as causing either a loss of gene product, such as in fragile X mental retardation, or an expansion of a polyglutamine region of a protein, as was first shown in spinobulbar muscular atrophy (Kennedy's disease). The pathogenic effect of the repeat expansion in myotonic dystrophy type 1, however, has been controversial because it does not encode a protein but nonetheless results in a highly penetrant dominant disease. Clinical and molecular characterization of myotonic dystrophy types 1 and 2 have now demonstrated a novel disease mechanism involving pathogenic effects of repeat expansions that are expressed in RNA but are not translated into protein. Copyright © 2005 by Current Science Inc.
引用
收藏
页码:55 / 60
页数:5
相关论文
共 57 条
[1]  
Harper P.S., Myotonic Dystrophy, 37, (2001)
[2]  
Brook J.D., McCurrah M.E., Harley H.G., Et al., Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member, Cell, 68, pp. 799-808, (1992)
[3]  
Fu Y.H., Pizzuti A., Fenwick Jr. R.G., Et al., An unstable triplet repeat in a gene related to myotonic muscular dystrophy, Science, 255, pp. 1256-1258, (1992)
[4]  
Ricker K., Koch M.C., Lehmann-Horn F., Et al., Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts, Neurology, 44, pp. 1448-1452, (1994)
[5]  
Thornton C.A., Griggs R.C., Moxley R.T., Myotonic dystrophy with no trinucleotide repeat expansion, Ann. Neurol., 35, pp. 269-272, (1994)
[6]  
Moxley R., Proximal myotonic myopathy: Mini-review of a recently delineated clinical disorder, Neuromusc. Disord., 6, pp. 87-93, (1996)
[7]  
Udd B., Krahe R., Wallgren-Petterson C., Et al., Proximal myotonic dystrophy - A family with autosomal domiant muscular dystrophy, cataracts, hearing loss and hypogonadism: Heterogeneity of proximal myotonic syndromes?, Neuromusc. Disord., 7, pp. 217-228, (1997)
[8]  
Ranum L., Rasmussen P., Benzow K., Et al., Genetic mapping of a second myotonic dystrophy locus, Nat. Genet., 19, pp. 196-198, (1998)
[9]  
Day J.W., Roelofs R., Leroy B., Et al., Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2), Neuromuscul. Disord., 9, pp. 19-27, (1999)
[10]  
New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1), Neurology, 54, pp. 1218-1221, (2000)